Results 231 to 240 of about 1,078,147 (263)

Clinical predictors of prognosis in patients with advanced non-small cell lung cancer receiving immunotherapy. [PDF]

Medicine (Baltimore)
Qiao Z, Pang L, Zheng H.
europepmc   +1 more source

Patient-derived organoids in non-small cell lung cancer: advances in drug sensitivity testing. [PDF]

Front Pharmacol
Tang W, Tian X.
europepmc   +1 more source

Steric disruption of EGFR oligomerization overcomes therapy resistance in non-small cell lung cancer. [PDF]

Sci Adv
Song D, Jang J, Lin MZ, Jung Y.
europepmc   +1 more source

Mebendazole inhibits PELI3-mediated ubiquitination of TRADD in non-small cell lung cancer cells. [PDF]

Front Oncol
Li F, Li X, Li H, Li S, Liu Y, Bai X, Qi T, Zhao X, He Y.   +8 more
europepmc   +1 more source

Deep-Learning Serial CT Prediction of Survival in Immunotherapy-Treated Non-Small Cell Lung Cancer.

JAMA Netw Open
Sako C, Kurland BF, Schmidt TG, He J, De Groot M, Patel AA, Owen DH, Amini A, Curti BD, Kelly RJ, Page RD, Swalduz A, Beregi JP, Chrusciel J, Sanchez S, Weiss J, Liu A, Gevaert O, Hart A, Simon GR, Parikh RB, van der Aart J, Jordan P.   +22 more
europepmc   +1 more source

Treatment options and considerations for acquired resistance in EGFR mutation-positive non-small-cell lung cancer. [PDF]

ESMO Open
Le X, Popat S, Heymach JV, West H, Zhang L.   +4 more
europepmc   +1 more source

LEAP-008: pembrolizumab plus lenvatinib after immunotherapy in non-small cell lung cancer. [PDF]

J Thorac Dis
Fukuda K.
europepmc   +1 more source

Metagenes Associated with Survival in Non-Small Cell Lung Cancer

Cancer Informatics, 2011
Egon Urgard, Tõnu Vooder, Urmo Võsa, Kristjan Välk, Mingming Liu, Cheng Luo, Fabian Hoti, Retlav Roosipuu, Tarmo Annilo, Jukka Laine, Christopher M. Frenz, Liqing Zhang, Andres Metspalu   +12 more
doaj